CFN
AIM

Cordasco Financial Network’s AIM ImmunoTech AIM Stock Holding History

Cordasco Financial Network’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Hold
5
– – ﹤0.01% 618
2022
Q1 		$1K Buy
+5
New +$431 ﹤0.01% 547

Other funds holding AIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cordasco Financial Network's AIM Position: Q2 2022 in Review

Cordasco Financial Network held its AIM ImmunoTech (AIM) position steady in Q2 2022 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #618.

Cordasco Financial Network first reported a position in AIM in Q1 2022 and has held it in 2 quarters since. The position peaked at $1K in Q1 2022. 36 funds tracked by Wall St. Rank hold AIM as of Q2 2022.

  • Cordasco Financial Network held 5 shares of AIM ImmunoTech worth $0 as of Q2 2022.
  • Cordasco Financial Network left its AIM ImmunoTech share count unchanged in Q2 2022.
  • AIM ImmunoTech made up ﹤0.01% of Cordasco Financial Network's portfolio in Q2 2022, its #618 holding.
  • Cordasco Financial Network first reported a position in AIM ImmunoTech in Q1 2022 and has held it in 2 quarters since.
  • Cordasco Financial Network's AIM ImmunoTech position peaked at $1K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2022.

Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.